97 related articles for article (PubMed ID: 25729402)
1. A Study into the Evolutionary Divergence of the Core Promoter Elements of
Rose AM; Shah AZ; Alfano G; Bujakowska KM; Barker AF; Robertson JL; Rahman S; Sánchez LV; Diaz-Corrales FJ; Chakarova CF; Krishna A; Bhattacharya SS
J Mol Genet Med; 2013 Aug; 7(2):. PubMed ID: 25729402
[TBL] [Abstract][Full Text] [Related]
2. Expression of PRPF31 and TFPT: regulation in health and retinal disease.
Rose AM; Shah AZ; Waseem NH; Chakarova CF; Alfano G; Coussa RG; Ajlan R; Koenekoop RK; Bhattacharya SS
Hum Mol Genet; 2012 Sep; 21(18):4126-37. PubMed ID: 22723017
[TBL] [Abstract][Full Text] [Related]
3. Variant haploinsufficiency and phenotypic non-penetrance in PRPF31-associated retinitis pigmentosa.
Rose AM; Bhattacharya SS
Clin Genet; 2016 Aug; 90(2):118-26. PubMed ID: 26853529
[TBL] [Abstract][Full Text] [Related]
4. A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease.
Abu-Safieh L; Vithana EN; Mantel I; Holder GE; Pelosini L; Bird AC; Bhattacharya SS
Mol Vis; 2006 Apr; 12():384-8. PubMed ID: 16636657
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of PRPF31 gene expression by MSR1 repeat elements causes incomplete penetrance in retinitis pigmentosa.
Rose AM; Shah AZ; Venturini G; Krishna A; Chakravarti A; Rivolta C; Bhattacharya SS
Sci Rep; 2016 Jan; 6():19450. PubMed ID: 26781568
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the PRPF31 Gene in Spanish Autosomal Dominant Retinitis Pigmentosa Patients: A Novel Genomic Rearrangement.
Martin-Merida I; Sanchez-Alcudia R; Fernandez-San Jose P; Blanco-Kelly F; Perez-Carro R; Rodriguez-Jacy da Silva L; Almoguera B; Garcia-Sandoval B; Lopez-Molina MI; Avila-Fernandez A; Carballo M; Corton M; Ayuso C
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1045-1053. PubMed ID: 28192796
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa.
Martínez-Gimeno M; Gamundi MJ; Hernan I; Maseras M; Millá E; Ayuso C; García-Sandoval B; Beneyto M; Vilela C; Baiget M; Antiñolo G; Carballo M
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2171-7. PubMed ID: 12714658
[TBL] [Abstract][Full Text] [Related]
8. Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue.
Rodrigues A; Slembrouck-Brec A; Nanteau C; Terray A; Tymoshenko Y; Zagar Y; Reichman S; Xi Z; Sahel JA; Fouquet S; Orieux G; Nandrot EF; Byrne LC; Audo I; Roger JE; Goureau O
NPJ Regen Med; 2022 Aug; 7(1):39. PubMed ID: 35974011
[TBL] [Abstract][Full Text] [Related]
9. Two trans-acting eQTLs modulate the penetrance of PRPF31 mutations.
Rio Frio T; Civic N; Ransijn A; Beckmann JS; Rivolta C
Hum Mol Genet; 2008 Oct; 17(20):3154-65. PubMed ID: 18640990
[TBL] [Abstract][Full Text] [Related]
10. Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa.
Sullivan LS; Bowne SJ; Seaman CR; Blanton SH; Lewis RA; Heckenlively JR; Birch DG; Hughbanks-Wheaton D; Daiger SP
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4579-88. PubMed ID: 17003455
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa.
Waseem NH; Vaclavik V; Webster A; Jenkins SA; Bird AC; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1330-4. PubMed ID: 17325180
[TBL] [Abstract][Full Text] [Related]
12. Mutation c. 1142 del G in the PRPF31 gene in a family with autosomal dominant retinitis pigmentosa (RP11) and its implications.
Taira K; Nakazawa M; Sato M
Jpn J Ophthalmol; 2007; 51(1):45-8. PubMed ID: 17295140
[TBL] [Abstract][Full Text] [Related]
13. PRPF31 alternative splicing and expression in human retina.
Tanackovic G; Rivolta C
Ophthalmic Genet; 2009 Jun; 30(2):76-83. PubMed ID: 19373678
[TBL] [Abstract][Full Text] [Related]
14. Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: An approach of gene therapy to treat retinitis pigmentosa.
Pensado A; Diaz-Corrales FJ; De la Cerda B; Valdés-Sánchez L; Del Boz AA; Rodriguez-Martinez D; García-Delgado AB; Seijo B; Bhattacharya SS; Sanchez A
Nanomedicine; 2016 Nov; 12(8):2251-2260. PubMed ID: 27381066
[TBL] [Abstract][Full Text] [Related]
15. Human organotypic retinal flat-mount culture (HORFC) as a model for retinitis pigmentosa11.
Azizzadeh Pormehr L; Daftarian N; Ahmadian S; Rezaei Kanavi M; Ahmadieh H; Shafiezadeh M
J Cell Biochem; 2018 Aug; 119(8):6775-6783. PubMed ID: 29744916
[TBL] [Abstract][Full Text] [Related]
16. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance?
Vithana EN; Abu-Safieh L; Pelosini L; Winchester E; Hornan D; Bird AC; Hunt DM; Bustin SA; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4204-9. PubMed ID: 14507862
[TBL] [Abstract][Full Text] [Related]
17. A novel 7 bp deletion in PRPF31 associated with autosomal dominant retinitis pigmentosa with incomplete penetrance in an Indian family.
Saini S; Robinson PN; Singh JR; Vanita V
Exp Eye Res; 2012 Nov; 104():82-8. PubMed ID: 23041261
[TBL] [Abstract][Full Text] [Related]
18. Novel Mutations in PRPF31 Causing Retinitis Pigmentosa Identified Using Whole-Exome Sequencing.
Xiao X; Cao Y; Zhang Z; Xu Y; Zheng Y; Chen LJ; Pang CP; Chen H
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6342-6350. PubMed ID: 29260190
[TBL] [Abstract][Full Text] [Related]
19. Course of Ocular Function in PRPF31 Retinitis Pigmentosa.
Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA
Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129
[TBL] [Abstract][Full Text] [Related]
20. Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.
Brambillasca F; Mosna G; Ballabio E; Biondi A; Boulukos KE; Privitera E
Biochem Biophys Res Commun; 2001 Nov; 288(5):1250-7. PubMed ID: 11700047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
